Advertisement
Canada markets open in 2 hours 43 minutes
  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CAD/USD

    0.7309
    -0.0012 (-0.16%)
     
  • CRUDE OIL

    78.28
    -0.20 (-0.25%)
     
  • Bitcoin CAD

    87,588.59
    -128.59 (-0.15%)
     
  • CMC Crypto 200

    1,324.35
    -40.78 (-2.99%)
     
  • GOLD FUTURES

    2,321.90
    -9.30 (-0.40%)
     
  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • NASDAQ futures

    18,173.25
    -22.25 (-0.12%)
     
  • VOLATILITY

    13.55
    +0.06 (+0.44%)
     
  • FTSE

    8,299.19
    +85.70 (+1.04%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6787
    -0.0005 (-0.07%)
     

Khiron CEO Alvaro Torres Talks Trailblazing in Colombia and Expanding Operations

Toronto, Ontario--(Newsfile Corp. - September 18, 2019) - Capital 10X President Evan Veryard sits down with Khiron Life Sciences (TSXV: KHRN) CEO Alvaro Torres.

They discuss Khiron's Colombian operations, expansion plans, and whether Khiron is on track to meet analyst expectations.



Cannot view this video? Visit:
https://capital10x.com/khiron-khrn-ceo-alvaro-torres-colombia-operations/

For more information, please contact:

Capital 10X
Evan Veryard, President
416-571-9037

Corporate Logo
Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47907